| abnormal expression of the CD11c gene characteristic of hairy cell leukemia is dependent upon activation of the proto-oncogenes ras and junD | leukemia, |
| LOH of chromosome 12p was seen in about 50% of human lung adenocarcinomas & large cell carcinomas. Kras2 mutations were seen at codon 12 in about 40% of adenocarcinomas & large cell carcinomas. The wild-type Kras2 is a tumor suppressor of lung cancer. | lung, |
| Met receptor overexpression and oncogenic Ki-ras mutation cooperate to enhance tumorigenicity of colon cancer cells in vivo. | colorectal, |
| K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study. | colorectal, |
| The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice. | pancreatic,gastric,HNSC, |
| Murine models of colorectal cancer: studying the role of oncogenic K-ras. | colorectal, |
| induction by oncogenic ras in LoVo and Colo320HSR colon cancer cell lines | colorectal, |
| MHC class I antigen expression is inversely related with tumor malignancy and ras oncogene product (p21ras) levels in human breast tumors. | breast, |
| The expression of the ras p21 oncoprotein in the bone marrow smears of children with acute leukemia. | leukemia, |
| Ki-ras oncogene activation in preinvasive pancreatic cancer. | pancreatic, |
| Expression of ras proto-oncogene related protein p21 in normal human skin and cutaneous tumours. | skin, |
| Cholangiocarcinomas in Japanese and Thai patients: difference in etiology and incidence of point mutation of the c-Ki-ras proto-oncogene. | cholangiocarcinoma, |
| Preliminary study on oncogene product immunohistochemistry (c-erbB-2, c-myc, ras p21, EGFR) in breast pathology. | breast, |
| [Expression of c-myc and c-ki-ras oncogene in human pancreatic carcinoma]. | pancreatic, |
| [Detection of point mutations of C-Ki-ras oncogene in colon cancer by PCR using specific oligonucleotide probes]. | colorectal, |
| Mutations of the Ki-ras oncogene in endometrial carcinoma. | endometrial, |
| Mutational analysis of a dominant oncogene (c-Ki-ras-2) and a tumor suppressor gene (p53) in hamster lung tumorigenesis. | lung, |
| Absence of point mutation in codons 12 and 13 of K-RAS oncogene in HPV-associated high grade dysplasia and squamous cell cervical carcinoma. | cervical, |
| findings indicate the wild-type KRAS allele is occasionally lost in lung cancer and the oncogenic activation of mutant KRAS is more frequently associated with overexpression of the mutant allele than with loss of the wild-type allele in NSCLC development | lung, |
| Oncogene Protein p21(ras) accumulation was confined to the upper layer of esophageal squamous cell carcinoma. | esophageal, |